Question is, what will that potential translate into pricewise upon MHRA approval. I've seen estimates ranging from a modest increase to some suggesting $5 or 6 and more. If there isn't a strong move, will momentum fail and the price retreat back?
I don't hold it, but Thermo has an interest in OTLK, so I check in on it from time to time. Biotech with a treatment for retinal disease. Price collapsed following a regulator rejection a few years ago, but the company persevered and finally got a FHMA approval July 8th, just days ago. The reaction has been muted, only about a 70-cent move on a 7-dollar stock. Now I know you can't really compare OTLK to NWBO, but the large short position in the latter will fight to keep the price down and AF and his ilk will likely be involved in some shenanigans to hold the price down. I keep my expectations low - would be happy if the share price got into the dollar range and held it, two dollars would be great for now.
Market Data 
Markets 
AI
